Product Information
ROPINIROLE HCL 3 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0848 per EA under NDC 43547027210. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
3 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547027210
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078110On Market Since
9/20/2011
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 3 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 28.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0848 per EA |
|---|---|
| All-time high | $0.1534 (Apr 16, 2014) |
| All-time low | $0.0575 (Nov 20, 2024) |
| 52-week high | $0.0848 |
| 52-week low | $0.0795 |
| Median price | $0.0960 |
| Average price | $0.0979 |
| Largest weekly change | +39.8% (Dec 19, 2018) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 3 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0848 per EA (NDC 43547027210), effective Jun 24, 2026.
How has the price of ROPINIROLE HCL 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 3 MG TABLET has declined 28.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 3 MG TABLET?
Since Nov 28, 2013, the NADAC for ROPINIROLE HCL 3 MG TABLET has ranged from a low of $0.0575 (Nov 20, 2024) to a high of $0.1534 (Apr 16, 2014), with a median of $0.0960 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 3 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ROPINIROLE HCL 3 MG TABLET, but none are currently priced below it.
Who manufactures ROPINIROLE HCL 3 MG TABLET?
ROPINIROLE HCL 3 MG TABLET (NDC 43547027210) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification